ClinicalTrials.Veeva

Menu

Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy (LiangAH)

T

The First Affiliated Hospital of Anhui Medical University

Status

Completed

Conditions

Robotic Surgical Procedures
Renal Cell Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT06317207
PJ2024-01-44
2019b07030004 (Other Grant/Funding Number)

Details and patient eligibility

About

To evaluate the safety of reoperation in patients with renal tumors who have ipsilateral tumor recurrence after nephron-sparing partial nephrectomy.

Enrollment

15 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ipsilateral local rRCC (any recurrence in the ipsilateral kidney and retroperitoneum)

Exclusion criteria

  1. With distant metastasis;
  2. Lacking essential sugery information.

Trial design

15 participants in 1 patient group

observation group
Description:
patients who underwent reoperation for locally rRCC after pNSS

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems